Sodium‐Glucose Co‐Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Sodium‐Glucose Co‐Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Background Sodium‐glucose co‐transporter (SGLT) inhibitors reduce cardiovascular outcomes including mortality in several populations; however, their effect on atrial fibrillation/flutter (AF) remains unclear. Our objective was to determine whether SGLT inhibitors reduce AF and whether a history of A...

Full description

Bibliographic Details
Main Authors: Arjun K. Pandey, Iva Okaj, Hargun Kaur, Emilie P. Belley‐Cote, Jia Wang, Alireza Oraii, Alexander P. Benz, Linda S. B. Johnson, Jack Young, Jorge A. Wong, Subodh Verma, David Conen, Hertzel Gerstein, Jeff S. Healey, William F. McIntyre
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
atrial fibrillation
atrial flutter
gliflozins
SGLT inhibitors
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.022222

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.022222

Similar Items